Living Cell Technologies Limited
LVCLY · OTC
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | – | $0 | $0 | $0 |
| Gross Profit | – | $0 | $0 | $0 |
| % Margin | – | – | 100% | – |
| R&D Expenses | – | $0 | $0 | $1 |
| G&A Expenses | – | $0 | $0 | $0 |
| SG&A Expenses | – | $1 | $0 | $0 |
| Sales & Mktg Exp. | – | $0 | $0 | $0 |
| Other Operating Expenses | – | $0 | $0 | $0 |
| Operating Expenses | – | $2 | $1 | $1 |
| Operating Income | – | -$2 | -$1 | -$1 |
| % Margin | – | – | -1,948.7% | – |
| Other Income/Exp. Net | – | -$0 | -$0 | -$0 |
| Pre-Tax Income | – | -$1 | -$1 | -$1 |
| Tax Expense | – | $0 | $0 | $0 |
| Net Income | – | -$1 | -$1 | -$1 |
| % Margin | – | – | -1,906.7% | – |
| EPS | – | -0.009 | -0.005 | -0.01 |
| % Growth | – | -80% | 50% | – |
| EPS Diluted | – | -0.009 | -0.005 | -0.01 |
| Weighted Avg Shares Out | – | 164 | 146 | 130 |
| Weighted Avg Shares Out Dil | – | 164 | 146 | 130 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $0 | $0 | $0 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | – | $0 | $0 | $0 |
| EBITDA | – | -$1 | -$0 | -$1 |
| % Margin | – | – | -801.4% | – |